Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate the Feasibility of a Treatment Algorithm in Newly Diagnosed Asthmatic Children. An Open Follow-up to Asthma Prevention in Infants/Young Children (PAC)

NCT00233584 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00233584
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00233584 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate the Feasibility of a Treatment Algorithm in Newly Diagnosed Asthmatic Children. An Open Follow-up to Asthma Prevention in Infants/Young Children (PAC)
Lead sponsor
AstraZeneca
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2001
Completion date
June 30, 2006
Enrollment
400
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma